Background illustration for clinical trials search

Paid Clinical Trials Illinois

Discover 2,576 paid clinical trials in Illinois. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study of Brenipatide in Participants With Alcohol Use Disorder

for
Alcohol Use Disorder
Location: Boston MA, Foxborough MA, Providence RI, The Bronx NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07219953

Phase3, Recruiting

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

for
Proteinuric Kidney Disease
Location: Bloomfield CT, Laurelton NY, Maspeth NY, Jersey City NJ,
Sponsor: Maze Therapeutics

Sex: All

Age: 18 - 68

Code: NCT06830629

Phase2, Recruiting

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

for
Locally Advanced Adrenal Cortical Carcinoma,
Location: Boston MA, Commack NY, Uniondale NY, Harrison NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT06900595

Phase2, Recruiting

STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission

for
Ulcerative Colitis (UC)
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18 - 70+

Code: NCT06693310

Recruiting

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

for
Breast Neoplasms
Location: Westbrook ME, Burlington MA, New York NY,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07173751

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer (CRC)
Location: Providence RI, Norwich CT, Hartford CT, New Haven CT,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT07228832

Phase3, Recruiting

Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation

for
Atrial Fibrillation (AF), Persistant Atrial Fibrillation,
Location: Charleston SC, Orlando FL, Jacksonville FL,
Sponsor: Arga Medtech SA

Sex: All

Age: 18 - 70+

Code: NCT06784466

Recruiting

A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy

for
Symptomatic Genetic Dilated Cardiomyopathy
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Kardigan, Inc.

Sex: All

Age: 18+

Code: NCT07210723

Phase2, Phase3, Recruiting
Featured

A Study to Assess the Adverse Events and How Oral ABBV-1042 Moves Through the Body of Healthy Adult Participants

for
Healthy Volunteer
Location: Grayslake IL
Sponsor: AbbVie

Sex: All

Age: 18 - 55

Code: NCT07222709

Phase1, Recruiting

Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)

for
Primary Membranous Nephropathy
Location: New York NY, Miami FL, Winter Park FL, Orlando FL,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 70+

Code: NCT07204275

Phase2, Phase3, Recruiting

Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

for
Schizophrenia
Location: South Dartmouth MA, Boston MA, New York NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07101094

Recruiting

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Brewer ME, Rockport ME, Brunswick ME, South Portland ME,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06876714

Phase3, Recruiting

Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy

for
Allergic Reactions
Location: New York NY, Washington D.C. DC, Ann Arbor MI,
Sponsor: ARS Pharmaceuticals, Inc.

Sex: All

Age: 4+

Code: NCT06834165

Recruiting

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

for
Castration-Sensitive Prostate Carcinoma,
Location: Stony Brook NY, Commack NY, Berlin Corners VT,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: Male

Age: 18+

Code: NCT06931340

Phase3, Recruiting

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

for
Buccal Mucosa Squamous Cell Carcinoma,
Location: New Haven CT, Lebanon NH, Commack NY, Trumbull CT,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT04333537

Phase2, Phase3, Recruiting

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Boston MA, New York NY, Hackensack NJ,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06973187

Phase3, Recruiting

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

for
Geographic Atrophy (GA),
Location: Waterford CT, Springfield MA, Westbury NY, Oceanside NY,
Sponsor: ONL Therapeutics

Sex: All

Age: 55+

Code: NCT06659445

Phase2, Recruiting

Minima Stent System Post- Approval Study (PAS)

for
Pulmonary Artery Stenosis, Aortic Coarctation
Location: Boston MA, Charlottesville VA, Miami FL, Pittsburgh PA,
Sponsor: Renata Medical

Sex: All

Age: 0+

Code: NCT06828770

Recruiting

A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

for
Pulmonary Sarcoidosis
Location: New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Xentria, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05890729

Phase1, Phase2, Recruiting

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

for
Non-Small-Cell Lung Cancer,
Location: Lake Success NY, New York NY, Philadelphia PA, Ottawa,
Sponsor: ArriVent BioPharma, Inc.

Sex: All

Age: 18+

Code: NCT07185997

Phase3, Recruiting

Popular cities in Illinois

PlainfieldJolietPeoriaChicagoSpringfieldGlenviewNaperville